Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Current Assets: 2020-2024

Historic Current Assets for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to $266.3 million.

  • Tango Therapeutics' Current Assets fell 45.55% to $163.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.8 million, marking a year-over-year decrease of 45.55%. This contributed to the annual value of $266.3 million for FY2024, which is 23.14% down from last year.
  • As of FY2024, Tango Therapeutics' Current Assets stood at $266.3 million, which was down 23.14% from $346.5 million recorded in FY2023.
  • In the past 5 years, Tango Therapeutics' Current Assets ranged from a high of $492.3 million in FY2021 and a low of $193.6 million during FY2020.
  • Its 3-year average for Current Assets is $329.4 million, with a median of $346.5 million in 2023.
  • As far as peak fluctuations go, Tango Therapeutics' Current Assets spiked by 154.26% in 2021, and later fell by 23.78% in 2022.
  • Tango Therapeutics' Current Assets (Yearly) stood at $193.6 million in 2020, then surged by 154.26% to $492.3 million in 2021, then fell by 23.78% to $375.3 million in 2022, then declined by 7.66% to $346.5 million in 2023, then dropped by 23.14% to $266.3 million in 2024.